German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Royalty Pharma

Market Cap: €22.2b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Grand Pharmaceutical Group

Market Cap: €28.6b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Sanofi

Market Cap: €98.1b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Hikma Pharmaceuticals

Market Cap: €3.3b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Aspen Pharmacare Holdings

Market Cap: €42.3b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

Zoetis

Market Cap: €52.3b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Prestige Consumer Healthcare

Market Cap: €3.0b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Merck KGaA

Market Cap: €51.5b

Operates as a science and technology company in Germany and internationally.

Genomma Lab Internacional. de

Market Cap: €18.3b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Sanofi

Market Cap: €98.1b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Zoetis

Market Cap: €52.3b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Evolus

Market Cap: €456.3m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Halozyme Therapeutics

Market Cap: €7.3b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Gedeon Richter

Market Cap: €1.8t

Researches, develops, manufactures, markets, and sells pharmaceutical products.

Verano Holdings

Market Cap: €817.7m

Operates as a vertically integrated multi-state cannabis operator in the United States.

China Resources Pharmaceutical Group

Market Cap: €28.8b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Merck KGaA

Market Cap: €51.5b

Operates as a science and technology company in Germany and internationally.

Daiichi Sankyo Company

Market Cap: €6.4t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Consun Pharmaceutical Group

Market Cap: €12.5b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Amphastar Pharmaceuticals

Market Cap: €1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Kalbe Farma

Market Cap: €55.3t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

SCHOTT Pharma KGaA

Market Cap: €2.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Perrigo

Market Cap: €1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Viatris

Market Cap: €13.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Bayer

Market Cap: €35.4b

Operates as a life science company worldwide.

Novartis

Market Cap: €205.8b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Viatris

Market Cap: €13.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

SCHOTT Pharma KGaA

Market Cap: €2.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Merck KGaA

Market Cap: €51.5b

Operates as a science and technology company in Germany and internationally.

Shionogi

Market Cap: €2.3t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

GSK

Market Cap: €73.6b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Daiichi Sankyo Company

Market Cap: €6.4t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

CSL

Market Cap: €86.5b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Fortrea Holdings

Market Cap: €1.5b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.